Search This Blog

Wednesday, November 17, 2021

Santhera and ReveraGen: Successful FDA Pre-NDA Meeting for Vamorolone in Duchenne

https://www.marketscreener.com/quote/stock/SANTHERA-PHARMACEUTICALS-195471/news/Santhera-and-ReveraGen-Announce-Successful-FDA-Pre-NDA-Meeting-for-Vamorolone-in-Duchenne-Muscular-D-37049274/

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)